Life Sciences

PhRMA revises guidelines for clinical trials

Pharma Compliance Alert, April 29, 2009

Pharmaceutical companies should provide results summaries for all interventional clinical trials involving patients, according to revised industry guidance.

Companies should publish the summaries whether the FDA approves the medicines or the particular research programs have been discontinued

Read more about PhRMA's revised guidelines for clinical trials.